Use of opioids for treatment of osteoporotic pain.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  CLINICAL CASES IN MINERAL AND BONE METABOLISM

• Publication date

  2014-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.11138/CCMBM/2014.11.3.173PMID 25568648PMCID PMC4269138
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

  2013cited by this paper
• Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain.

  2012cited by this paper
• Adverse Effects Associated with Non-opioid and Opioid Treatment in Patients with Chronic Pain

  2012cited by this paper
• Opioids: How to Improve Compliance and Adherence

  2011cited by this paper
• Is the WHO analgesic ladder still valid? Twenty-four years of experience.

  2010cited by this paper
• Prevalence and correlates of musculoskeletal pain in Chinese elderly and the impact on 4-year physical function and quality of life.

  2009cited by this paper
• Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

  2009cited by this paper
• Endocrine consequences of opioid therapy.

  2009cited by this paper
• Adverse drug interactions involving common prescription and over-the-counter analgesic agents.

  2007cited by this paper
• [Bone diseases with Pain. Osteoporosis].

  2007cited by this paper
• Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids

  2005cited by this paper
• Direct clinical and welfare costs of osteoporotic fractures in elderly men and women

  2005cited by this paper
• Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs

  2005cited by this paper
• Chronic pain management -can we do better? An interview-based survey in primary care

  2003cited by this paper
• Assessment for Addiction in Pain-Treatment Settings

  2002cited by this paper
• Chronic pain: treatment barriers and strategies for clinical practice.

  2001cited by this paper
• Definitions related to the use of opioids for the treatment of pain.

  2001cited by this paper
• Chronic opioid therapy for non-cancer pain.

  2001cited by this paper
• Opiate withdrawal.

  1994cited by this paper
• Hip fractures in the elderly: A world-wide projection

  1992cited by this paper
• Perspective how many women have osteoporosis?

  1992cited by this paper
• Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism.

  1991cited by this paper
• Opioid pseudoaddiction--an iatrogenic syndrome.

  1989cited by this paper

• Osteoporosis pain management in Italy

  2024cites this paper
• Postdischarge opioid use and persistent use after general surgery: A retrospective study.

  2022cites this paper
• The social-cognitive determinants of calcium intake for preventing osteoporosis in women in Isfahan: A cross-sectional study using path analysis

  2021cites this paper
• TGF-Beta Induced Key Genes of Osteogenic and Adipogenic Differentiation in Human Mesenchymal Stem Cells and MiRNA–mRNA Regulatory Networks

  2021cites this paper
• Stachydrine hydrochloride inhibits osteoclastogenesis by regulating the NF-κB and p38 signaling pathways to alleviate postmenopausal osteoporosis.

  2021cites this paper
• Cinnamtannin B-1 Prevents Ovariectomy-Induced Osteoporosis via Attenuating Osteoclastogenesis and ROS Generation

  2020cites this paper
• The Development of a Macromolecular Analgesic for Arthritic Pain.

  2019cites this paper
• Proanthocyanidins inhibit osteoclast formation and function by inhibiting the NF-κB and JNK signaling pathways during osteoporosis treatment.

  2019cites this paper
• Understanding osteoporotic pain and its pharmacological treatment

  2018cites this paper
• Long-term benefits and risks of parathyroid hormone treatment in compliant osteoporotic patients. A Danish national register based cohort study

  2018cites this paper
• Effects of Teriparatide in Patients with Osteoporosis in Clinical Practice: 42-Month Results During and After Discontinuation of Treatment from the European Extended Forsteo® Observational Study (ExFOS)

  2018cites this paper
• What is the challenge? Up to 85% of patients with osteoporosis suffers from acute or chronic pain of different nociceptive and sometimes also neuropathic

  2018influential citation
• Osteoporosis in patients with intestinal insufficiency and intestinal failure: Prevalence and clinical risk factors.

  2017cites this paper
• Bone pain mechanism in osteoporosis: a narrative review.

  2016cites this paper
• Implications of analgesics use in osteoporotic-related pain treatment: focus on opioids.

  2016cites this paper
• Elevated CCL2/MCP-1 Levels are Related to Disease Severity in Postmenopausal Osteoporotic Patients.

  2016cites this paper
• The role of drugs in bone pain.

  2016cites this paper
• Prevention and Treatment of Bone Disease in Systemic Lupus Erythematosus

  2016cites this paper
• Pharmacology of pain management in general practice

  2016cites this paper
• Management of chronic pain in osteoporosis: challenges and solutions

  2016cites this paper
• Effects of Chitin Whiskers on Physical Properties and Osteoblast Culture of Alginate Based Nanocomposite Hydrogels.

  2015cites this paper